These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 201086)

  • 21. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunobiology of Epstein-Barr virus-associated lymphomas.
    Rochford R; Mosier DE
    Clin Immunol Immunopathol; 1994 Jun; 71(3):256-9. PubMed ID: 8200127
    [No Abstract]   [Full Text] [Related]  

  • 23. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.
    Rosén A; Gergely P; Jondal M; Klein G; Britton S
    Nature; 1977 May; 267(5606):52-4. PubMed ID: 193041
    [No Abstract]   [Full Text] [Related]  

  • 24. Epstein-Barr virus: adaptation to a life within the immune system.
    Masucci MG; Ernberg I
    Trends Microbiol; 1994 Apr; 2(4):125-30. PubMed ID: 8012755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.
    Sixbey JW; Pagano JS
    J Virol; 1985 Jan; 53(1):299-301. PubMed ID: 2981351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous lymphoblastoid cell lines in virological research].
    Melik-Andreasian GG; Barinskiĭ IF
    Vopr Virusol; 1980; (3):266-70. PubMed ID: 6254262
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME; Chan MA; Sigal NH
    J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus. Infection and tumour induction.
    Epstein MA
    Nature; 1986 Jun 12-18; 321(6071):653-4. PubMed ID: 3012366
    [No Abstract]   [Full Text] [Related]  

  • 33. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
    Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases.
    Henle W; Henle G
    Ann N Y Acad Sci; 1980; 354():326-31. PubMed ID: 6261650
    [No Abstract]   [Full Text] [Related]  

  • 36. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.
    Montagnier L; Gruest J; Chamaret S; Dauguet C; Axler C; Guétard D; Nugeyre MT; Barré-Sinoussi F; Chermann JC; Brunet JB
    Science; 1984 Jul; 225(4657):63-6. PubMed ID: 6328661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 38. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell transformation induced by Epstein-Barr virus--living dangerously.
    Rowe M
    Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
    [No Abstract]   [Full Text] [Related]  

  • 40. Ultraviolet inactivation of Epstein--Barr virus-induced nuclear antigen (EBNA), DNA and IgM synthesis in human B lymphocytes.
    Engblom I; Ernberg I
    Virology; 1981 Jul; 112(1):228-39. PubMed ID: 6264682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.